David Endicott

David Endicott is the CEO of Alcon, a prominent international company specializing in eye care products, including contact lenses and surgical equipment. He has been instrumental in steering the company toward significant growth following its spin-off from Novartis, with a focus on enhancing its presence in the U.S. market, which constitutes a large portion of its revenue.